U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07520292) titled 'Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder' on April 03.
Brief Summary: The primary goal of this Phase 1b clinical trial is to evaluate the effects of a novel TAAR1 receptor partial agonist (NTX-2001) in adults with Alcohol Use Disorder (AUD). The main questions this trial aims to answer are:
* Does NTX-2001 affect alcohol consumption in adults with AUD?
* Is NTX-2001 safe and well tolerated in adults with AUD?
Researchers will compare the effects of NTX-2001 with matching placebo (look-alike capsule that contains no drug).
Participants will:
* Take NTX-2001 or matching placebo every day for 2 weeks
* Vi...